RISK OF LEUKEMIA IN OVARIAN TUMOR AND BREAST-CANCER PATIENTS FOLLOWING TREATMENT BY CYCLOPHOSPHAMIDE

被引:89
作者
HAAS, JF
KITTELMANN, B
MEHNERT, WH
STANECZEK, W
MOHNER, M
KALDOR, JM
DAY, NE
机构
[1] AKAD WISSENSCH DDR,ZENTR INST KREBSFORSCH,NATL KREBSREGISTER & KREBSSTAT,DDR-1197 BERLIN JOHANNIST,GER DEM REP
[2] INT AGCY RES CANC,F-69372 LYON 08,FRANCE
关键词
D O I
10.1038/bjc.1987.40
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
引用
收藏
页码:213 / 218
页数:6
相关论文
共 27 条
[21]  
2-L
[22]   BLADDER COMPLICATIONS IN PATIENTS RECEIVING CYCLOPHOSPHAMIDE FOR SYSTEMIC LUPUS-ERYTHEMATOSUS OR RHEUMATOID-ARTHRITIS [J].
PLOTZ, PH ;
KLIPPEL, JH ;
DECKER, JL ;
GRAUMAN, D ;
WOLFF, B ;
BROWN, BC ;
RUTT, G .
ANNALS OF INTERNAL MEDICINE, 1979, 91 (02) :221-223
[23]   ACUTE-LEUKEMIA AFTER ALKYLATING-AGENT THERAPY OF OVARIAN CANCER [J].
REIMER, RR ;
HOOVER, R ;
FRAUMENI, JF ;
YOUNG, RC .
NEW ENGLAND JOURNAL OF MEDICINE, 1977, 297 (04) :177-181
[24]   CARCINOGENIC ACTION OF LOW-DOSE CYCLOPHOSPHAMIDE GIVEN ORALLY TO SPRAGUE-DAWLEY RATS IN A LIFETIME EXPERIMENT [J].
SCHMAHL, D ;
HABS, M .
INTERNATIONAL JOURNAL OF CANCER, 1979, 23 (05) :706-712
[25]  
WATERHOUSE J, 1982, IARC SCI PUBLICAT 42, V4
[26]  
1981, IARC MONOGRAPHS EVAL, V26
[27]  
1986, CA CANCER J CLIN, V36, P42